The North America Veterinary Endocrinology Market is projected to witness market growth of 6.1% CAGR during the forecast period (2024-2031).
The US market dominated the North America Veterinary Endocrinology Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $129.89 millions by 2031. The Canada market is experiencing a CAGR of 8.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.6% during (2024 - 2031).
The adoption of veterinary endocrinology practices has evolved significantly over the years, driven by advancements in diagnostic capabilities, treatment options, and a growing recognition of the importance of hormonal balance in animal health.
Additionally, developing sensitive and specific hormone assays has revolutionized the diagnosis of endocrine disorders in animals. Veterinarians can now accurately measure hormone levels in blood, urine, or saliva samples, allowing for early detection and precise characterization of hormonal imbalances.
As Canada’s pet population grows, there is a corresponding increase in hormonal disorders among companion animals. Conditions such as thyroid disorders, diabetes mellitus, and adrenal gland diseases become more prevalent, driving up the demand for specialized veterinary endocrinology services.
The US market dominated the North America Veterinary Endocrinology Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $129.89 millions by 2031. The Canada market is experiencing a CAGR of 8.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.6% during (2024 - 2031).
The adoption of veterinary endocrinology practices has evolved significantly over the years, driven by advancements in diagnostic capabilities, treatment options, and a growing recognition of the importance of hormonal balance in animal health.
Additionally, developing sensitive and specific hormone assays has revolutionized the diagnosis of endocrine disorders in animals. Veterinarians can now accurately measure hormone levels in blood, urine, or saliva samples, allowing for early detection and precise characterization of hormonal imbalances.
As Canada’s pet population grows, there is a corresponding increase in hormonal disorders among companion animals. Conditions such as thyroid disorders, diabetes mellitus, and adrenal gland diseases become more prevalent, driving up the demand for specialized veterinary endocrinology services.
List of Key Companies Profiled
- Dechra Pharmaceuticals PLC (EQT AB)
- Elanco Animal Health Incorporated
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Zoetis, Inc.
- LLOYD, Inc.
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Mars, Inc. (Antech Diagnostics, Inc)
Market Report Segmentation
By Route of Administration- Oral and
- Other routes
- Dogs,
- Cats, and
- Other Animals
- Pancreatic Disorders, and
- Other Disorders
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Veterinary Endocrinology Market by Route of Administration
Chapter 5. North America Veterinary Endocrinology Market by Animal Type
Chapter 6. North America Veterinary Endocrinology Market by Application
Chapter 7. North America Veterinary Endocrinology Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Dechra Pharmaceuticals PLC (EQT AB)
- Elanco Animal Health Incorporated
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Zoetis, Inc.
- LLOYD, Inc.
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Mars, Inc. (Antech Diagnostics, Inc)
Methodology
LOADING...
